[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-369337-105":59,"doc-detail-369337-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","geographic-disparities-in-gastrointestinal-oncology-research-a-focus-on-trial-availability-in-italy","Geographic disparities in gastrointestinal oncology research - A focus on trial availability in Italy","","Gastrointestinal cancers create substantial global burden through high incidence and mortality. Oncology clinical trials can improve outcomes and provide access to advanced therapies, yet trial access may vary geographically. This study retrospectively assessed active interventional trials in Italy from March 1, 2020 to March 1, 2024 using clinicaltrials.gov, mapping 630 study locations across 103 active trials.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/geographic-disparities-in-gastrointestinal-oncology-research-a-focus-on-trial-availability-in-italy/369337/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/geographic-disparities-in-gastrointestinal-oncology-research-a-focus-on-trial-availability-in-italy/369337.png","ImageObject",300,407,{"name":92,"@type":93},"Aurelia","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-30","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What timeframe and data source were used to evaluate trial availability in Italy?","Question",{"text":112,"@type":113},"The study retrospectively reviewed active interventional clinical trials in Italy in the period March 1, 2020 to March 1, 2024 using a search on clinicaltrials.gov.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were the geographic disparities in trial availability analyzed?",{"text":117,"@type":113},"Locations of active trials were extracted for each study, totaling 630 locations. A kernel smoothing approach was used to reveal clustering patterns and estimate probability density.",{"name":119,"@type":110,"acceptedAnswer":120},"What conclusions does the study draw about trial distribution across Italy?",{"text":121,"@type":113},"Trial availability clusters in Northern and Central Italy, while Southern regions and islands show lower availability. The uneven distribution limits treatment options and may affect the representativeness of trial data, supporting targeted strategies to improve accessibility.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},369337,1790788069,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":39,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":46,"preview_page_count":19,"preview_urls":144},1099514068365,"https://ap-avatar.wpscdn.com/avatar/10000253d8d9f28188e?x-image-process=image/resize,m_fixed,w_180,h_180&k=1794309523707217728","Geographic disparities in gastrointestinal oncology research: a focus on trial availability in Italy  \nMaurizio Polignano*, Nicola Carella, Ornella Rotolo, Natalino Vena, Vincenza Lorusso, Giuseppe Dalfino, Gianluigi Giannelli  \nNational Institute of Gastroenterology-IRCCS “Saverio de Bellis,” 70013 Castellana Grotte, Italy  \n* Corresponding author: National Institute of Gastroenterology-IRCCS “Saverio de Bellis,” via Turi 27, 70013 Castellana Grotte (BA), Puglia, Italy (maurizio. [polignano@irccsdebellis.it](polignano@irccsdebellis.it)) .  \nAbstract  \nBackground: Gastrointestinal cancers pose a significant global health burden, bearing as they do high incidence and mortality rates. Clinical trials in oncology offer numerous advantages as helping to develop new treatments and improve existing ones, leading to better patient outcomes, providing patients with access to cutting-edge therapies that might not otherwise be available and enhancing our understanding of cancer biology.  \nMethods: We retrospectively reviewed active interventional clinical trials in Italy in the field of gastrointestinal neoplasms in the period March 1, 2020 and March 1, 2024, by a search on the “[clincaltrials.gov](clincaltrials.gov)” database. The search yielded 103 studies active in Italy. For each study, the Centers in Italy at which they are active were extracted. Studies resulted active in a total of 630 locations.  \nResults: The data analysis, by a kernel smoothing for probability density estimation, reveals a pronounced clustering of trials in Northern and Central Italy, while the Southern regions and islands exhibit lower trial availability, highlighting disparities in patient access. The mean number of clinical trials per 100 000 inhabitants was calculated. We found that Northern regions show a much higher concentration compared with the Southern regions and islands (North-east 0.92 CTs/100 000 inhabitants vs Islands 0.53 CTs/100 000 inhabitants) .  \nConclusions: The uneven distribution does not only limit treatment options for patients in less accessible areas but also raises concerns about the representativeness of trial data. This study underscores the need for targeted strategies to enhance trial accessibility, including decentralized trial models and national databases, to ensure equitable patient participation across Italy.  \nKey words: oncology; inequity of access; clinical trials; gastrointestinal cancers; North–South divide.  \nImplications for Practice  \nThe effectiveness of clinical research is based on the ability to enroll patients within a short-time frame and to evaluate the results found based on a sample as representative as possible of the National population. The availability of very up-to-date data on the distribution of clinical trials in Italy on GI tumors can help Promoters to identify areas that guarantee satisfactory enrollment as well as patients in identifying a Center at which to access experimental treatments.  \nIntroduction  \nGastrointestinal cancer includes malignant conditions of the gastrointestinal tract (GI tract) and accessory organs of digestion, the esophagus, stomach, biliary system, pancreas, small intestine, large intestine, rectum, and anus. The symptoms relate to the organ affected and can include obstruction (leading to difficulty in swallowing or defecating), abnormal bleeding, or other associated problems. The diagnosis often requires endoscopy, followed by biopsy of suspicious tissue. The treatment depends on the location of the tumor, as well as the type of cancer cell and whether it has invaded other tissues or spread elsewhere. These factors also determine the prognosis.  \nOverall, the GI tract and the accessory organs of digestion (pancreas, liver, gall bladder) are responsible for more cancersand more deaths from cancer than any other system in the  \nbody.1,2 There is a significant geographic variation in the rates of different gastrointestinal cancers.3 There were an estimated 4.8 million new ","cbCaicQMUbUh2yAF","https://ap.wps.com/l/cbCaicQMUbUh2yAF","pdf",1043617,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Implications for Practice\n# Introduction","[{\"question\":\"What timeframe and data source were used to evaluate trial availability in Italy?\",\"answer\":\"The study retrospectively reviewed active interventional clinical trials in Italy in the period March 1, 2020 to March 1, 2024 using a search on clinicaltrials.gov.\"},{\"question\":\"How were the geographic disparities in trial availability analyzed?\",\"answer\":\"Locations of active trials were extracted for each study, totaling 630 locations. A kernel smoothing approach was used to reveal clustering patterns and estimate probability density.\"},{\"question\":\"What conclusions does the study draw about trial distribution across Italy?\",\"answer\":\"Trial availability clusters in Northern and Central Italy, while Southern regions and islands show lower availability. The uneven distribution limits treatment options and may affect the representativeness of trial data, supporting targeted strategies to improve accessibility.\"}]","Geographic disparities in gastrointestinal oncology research - A focus on trial availability in Italy | PDF",1790182111,[145,149,153,157],{"page_no":8,"url":146,"width":147,"height":148},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/01bfaade08bb4ef4412e9898940ad211.webp",983,1291,{"page_no":14,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6fafae36d184de207bd76a40f0aaeb8e.webp",982,1290,{"page_no":81,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9013500355be52708955e081b57eebe6.webp",981,1289,{"page_no":19,"url":158,"width":159,"height":160},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d53e64629669b3283015d506b90ffb2b.webp",980,1287]